Search Results
Found 1 results
510(k) Data Aggregation
(358 days)
The BeneHold™ Surgical Incise Drape with CHG is indicated for use as an incise drape with continuous antibacterial activity (in vitro) from 2.5 to 4 hours against the following organisms; S. epidermidis, E. faecalis, E. coli, P. aeruginosa and E. aerogenes.
It is intended for external use only. Correlation between in vitro results and any clinical event has not been tested.
Not Found
The provided document is a 510(k) clearance letter from the FDA for a medical device called "BeneHold™ Surgical Drape with CHG". This type of document does not contain the information requested regarding acceptance criteria and a study proving a device meets them in the context of a performance study (e.g., for an AI/ML powered device).
Instead, this document confirms that the device is substantially equivalent to a legally marketed predicate device and outline general regulatory requirements. It does not include performance data, expert qualifications, sample sizes for test/training sets, or details about comparative effectiveness studies.
The "Indications for Use" section mentions "continuous antibacterial activity (in vitro) from 2.5 to 4 hours against the following organisms; S. epidermidis, E. faecalis, E. coli, P. aeruginosa and E. aerogenes." This refers to laboratory testing of the antimicrobial properties of the drape, not a clinical study involving human patients or a performance study for an AI-powered device.
Therefore, I cannot extract the requested information from this document.
Ask a specific question about this device
Page 1 of 1